Creative Biolabs’ CAR-T Cell Solutions Accelerate the Research Process
New York, USA – January 22, 2024 – CAR-T therapy is emerging as a revolutionary approach to cancer treatment, harnessing the body’s immune system to target and eliminate cancer cells. The efficacy of CAR-T therapy relies on the precise design of CAR-T cells, ensuring optimal functionality and targeting specific cancer antigens. As a globally recognized biotechnology company based in the USA, Creative Biolabs is committed to providing comprehensive CAR cell solutions and products. Their team of experienced scientists is ready to respond to research demands and maximize the efficiency of clients’ projects.
“Our team of scientists, with years of experience in immunotherapy research, employs state-of-the-art techniques to engineer CAR-T cells with enhanced precision and efficacy. By incorporating the latest advancements in genetic engineering, our CAR-T cell designs exhibit improved targeting capabilities, reduced off-target effects, and enhanced persistence within the patient’s body,” said the senior scientist at Creative Biolabs.
Additionally, this company has developed a proprietary online system for customizing CAR and CAR cell products, which offers full options to meet all unique needs, including but not limited to conventional or unconventional CAR-T cell design and constructs, as well as a variety of vectors and cells.
Creative Biolabs introduces a comprehensive CAR cell in vitro assay platform. This platform serves as a crucial tool for researchers to evaluate the functionality and potency of CAR-T cells before clinical applications. The in vitro assays provide valuable insights into the behavior of engineered CAR-T cells, allowing researchers to optimize and fine-tune their designs for maximum therapeutic impact. The following assays are adopted by this company:
* CAR expression test
* Cytokine release test
* In vitro cytotoxicity test
* CAR cell proliferation test
* Viability and bio-distribution analysis
* Efficacy test
“In the new year, we will continue to refine our technology development platform, providing our customers with a more comprehensive and efficient CAR cell in vitro assay service,” emphasized the scientist.
Researchers, pharmaceutical companies, and institutions engaged in cancer immunotherapy research can now leverage Creative Biolabs’ end-to-end CAR-T cell services to streamline their workflows, reduce development timelines, bringing novel therapies to patients more efficiently.
Learn more about custom solutions for CAR-T cells at Creative Biolabs, please visit https://www.creative-biolabs.com/car-t.
About Creative Biolabs
Creative Biolabs is committed to improving human health with a focus on the field of immunotherapy, specifically CAR-T cell technologies. As the leading CRO offering CAR-T cell services, scientists at this company are confident in delivering complete solutions for clients’ projects.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/car-t
